Medication info
Acerano Tablets

Acerano Tablets

Prescription medicationTabletOral
Ingredient · strength
Acetaminophen›325mg / 1 tabletTramadol Hydrochloride›37.5mg / 1 tablet
Manufacturer / importer
CMG Pharmaceutical Co., Ltd.
Appearance
Light yellow, oblong film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201400343 · Approved 2014.01.24 · Insurance code 648602600

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Older adults Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when administered orally to older adults aged 75 years or older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended for patients with severe renal impairment (creatinine clearance less than 10ml/min). Since tramadol is removed very slowly by hemodialysis and filtration, there is no need to readminister this medicine after dialysis to maintain its analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.
Child dose
Children aged 12 years and older: Adjust the dose according to the patient's pain severity and response to treatment. The recommended initial dose is 2 tablets. Thereafter, leave an interval of at least 6 hours between doses and do not exceed 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term administration is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should continue.

Ingredients

Manufacturer
CMG Pharmaceutical Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Acute pain
  • chronic pain
View approved original text

This medication is used to relieve acute and chronic pain ranging from moderate to severe.

How to take

Adult dose

Older adults Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when administered orally to older adults aged 75 years or older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended for patients with severe renal impairment (creatinine clearance less than 10ml/min). Since tramadol is removed very slowly by hemodialysis and filtration, there is no need to readminister this medicine after dialysis to maintain its analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.

Child dose

Children aged 12 years and older: Adjust the dose according to the patient's pain severity and response to treatment. The recommended initial dose is 2 tablets. Thereafter, leave an interval of at least 6 hours between doses and do not exceed 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term administration is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should continue.

Precautions

This medication may pose a risk of liver damage for those who regularly consume more than three alcoholic beverages per day, and consultation with a physician or pharmacist is necessary. As it contains acetaminophen, there is a rare risk of serious skin reactions; skin rashes or hypersensitivity should lead to immediate discontinuation of use. Tramadol, one of its active ingredients, can increase the risk of seizures; care should be taken for individuals with a history of seizures or those taking medications that can induce seizures. Concomitant use of tramadol with certain antidepressants or opioid analgesics can further increase seizure risk. In patients with acute bronchial asthma, respiratory suppression can pose life-threatening risks, so administration should only be in settings equipped for such emergencies. This medication can cause severe drowsiness, respiratory depression, or coma when used with alcohol or central nervous system depressants, requiring careful administration and possibly avoidance. Caution is necessary for patients with elevated intracranial pressure or head injuries due to potential worsening of symptoms from respiratory depression. Tramadol can lead to psychological and physical dependence, so regular observation for dependence is essential in long-term use. Patients with impaired liver function are at risk of liver damage from acetaminophen, thus should consult a doctor before use. Especially for ultra-rapid CYP2D6 metabolizers, there is a possibility of a rapid increase in the active metabolite that may cause serious side effects such as respiratory depression, necessitating monitoring and dose adjustments. This medication should not be given to children under 12 years of age or to adolescents under 18 years who have undergone tonsillectomy or adenoidectomy. This medication may exacerbate sleep apnea; if symptoms are present or suspected, dose reduction or discontinuation should be considered. Elderly patients or those at risk for hyponatremia should be regularly monitored for the occurrence of hyponatremia. This medication is contraindicated or requires cautious use in patients with certain disorders or who are taking specific medications, and consultation with healthcare professionals is required before use. Drowsiness or dizziness may occur during use, so care should be taken when driving or operating machinery. In cases of overdose, serious respiratory depression, seizures, and liver damage can occur; thus, it is vital to adhere to prescribed doses and seek immediate medical attention for unusual symptoms. This medication must be stored out of reach of children and managed carefully to prevent misuse or abuse by others.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, hepatotoxicity, hyponatremia, loss of appetite, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, dyspepsia, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, urticaria, hypersensitivity, hypoglycemia, anxiety, nervousness, emotional instability, euphoria, decreased libido, sleep disturbances, confusion, disorientation, agitation, abnormal dreams, drug abuse, hallucinations, withdrawal syndrome, migraine, somnolence, sensory decrease, tremors, sensory disturbances, attention deficit, syncope, memory impairment, psychomotor agitation, sedation, amnesia, perception abnormalities, convulsions, blurred vision, visual impairment, miosis, dizziness, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, increased liver enzymes, generalized pruritus, sweating, urinary disturbances, erectile dysfunction, asthenia, chest pain, emotional abnormalities, chills, chest discomfort, malaise, thirst, irritability, heat sensation, weight loss, increased serum creatinine, anaphylactic reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis, effect on emotional instability, delirium, suicidal ideation, hypertonia, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, gait disturbances, prolonged prothrombin time, thrombocytopenia, agranulocytosis, blood disorders, pyrolglutamic acidosis, high anion gap metabolic acidosis, fixed rash, asthenia, fever, edema, rigidity, syncope, congestive heart failure, vertigo, confusion, exacerbation of migraine, involuntary muscle contractions, exercise-induced dyspnea, cough, bronchitis, urinary retention, increased frequency of urination, kidney function abnormalities, oliguria, increased sweating, dysphagia, tongue swelling, hypersalivation, progression of rectal cancer, progression of esophageal cancer, progression of gastric cancer, paralytic ileus, hiccups, cholecystitis, depersonalization, anemia, decreased hemoglobin, decreased red blood cells, increased white blood cells, leukocytosis, palpitations, arrhythmia, exacerbation of hypertension, aortic stenosis, hemorrhage, increased cholesterol, tinnitus, hip pain, thigh pain, allergic rhinitis, nasal bleeding, abnormal visual fields, progression of biliary tract cancer, foreign body sensation in the eye, progression of liver cancer, liver function abnormalities, nausea, dizziness, confusion, dyspnea, migraine, speech disorders, loss of consciousness, recurrence of myocardial infarction, hypotension, confusion, multiple organ failure, intentional overdosing, belching, chest discomfort, anxiety, sweating, rigidity, pain, upper respiratory syndrome, body hair growth, agitation, hyperactivity, panic attacks, severe anxiety, hallucinations, perception abnormalities, tinnitus, abnormal central nervous system reactions, urticaria, bronchospasm, toxic skin necrosis, opioid-induced hyperalgesia, withdrawal symptoms, decreased analgesic effect and increased risk of withdrawal symptoms when combined with opioid antagonists, QT prolongation, respiratory depression, somnolence, coma, cardiac arrest, death, abdominal discomfort, nausea, malaise, pallor, hyperhidrosis, nephron necrosis, coagulopathy, symptoms of acute or chronic adrenal insufficiency.

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container to avoid exposure to air and moisture. It is best to keep it at room temperature between 1°C and 30°C.

Appearance and packaging

Appearance

Light yellow, oblong film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.